ScaleWiki
Explore our comprehensive collection of scientific resources, from application notes and case studies to videos and webinars.
Share
Filter By
Cell Types
Filter by Year
Publications
CTL Cells
Generation of Tumor-Specific CD8+ T cells
This poster outlines a semi-automated GMP platform using artificial antigen presenting cells (aAPCs) to generate AML-specific CD8+ T cells. Following magnetic enrichment, the antigen-specific T cells were successfully expanded to clinically relevant numbers using G-REX expansion flasks over a 14-day period.
Publications
Car T Cells
Cell trajectory modulation: rapid microfluidic biophysical profiling of CAR T cell functional phenotypes
The Cell Trajectory Modulation (CTM) assay provides rapid, label-free profiling of CAR T cell biophysical features like size and deformability. The study compares CAR T cells manufactured in G-Rex gas-permeable plates versus perfusion bioreactors, showing that biophysical signatures correlate with potency and phenotype.
Publications
NK Cells
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR
This study demonstrates that NK cells engineered with mRNA to express an EphA2-targeted CAR exhibit enhanced cytotoxicity against pediatric sarcomas. The protocol involved expanding human primary NK cells in G-Rex 24 multi-well cell culture plates using supplemented NK MACS media and activation beads or feeder cells.
Publications
T-Cells
Dual modulation of cytotoxic and checkpoint receptors tunes the efficacy of adoptive Delta One T cell therapy against colorectal cancer
This study investigates the efficacy of Delta One T (DOT) cells against colorectal cancer. It identifies NKG2D ligand upregulation and simultaneous TIGIT/PD1 blockade as strategies to enhance cytotoxicity. The expansion protocol for producing clinical-grade DOT cells utilized the G-REX platform with OpTmizer-CTS medium.
Publications
Car T Cells
Affinity-tuned mesothelin CAR T cells demonstrate enhanced targeting specificity and reduced off-tumor toxicity
This study develops affinity-tuned mesothelin (MSLN) CAR T cells to improve specificity and safety. Low-affinity variants showed effective tumor control with reduced off-tumor toxicity in mice. CAR T cells were expanded in G-Rex 6M well plates during the manufacturing process.
Publications
TCR T Cells
Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients
This study identifies an HLA-A*11:01-restricted TCR targeting KRAS G12V from a pancreatic cancer patient. T cells engineered with this TCR were expanded in G-Rex 24-well plates and showed specific recognition of tumor organoids, enhanced by IFN-gamma priming.
Publications
VST Cells
Donor Variability and PD-1 Expression Limit BK Polyomavirus-specific T-cell Function and Therapy
This study compares conventional and G-Rex systems for expanding BKPyV-specific T cells. G-Rex cultures resulted in higher total cell counts but increased PD-1 expression. The study highlights the need for optimization in adoptive T-cell therapy protocols for BKPyV.
Publications
Car T Cells
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor That Unleashes PD-1 Checkpoint and CAR T-Cell Immunotherapies
This paper reports on BMS-986408, a dual DGK inhibitor that enhances PD-1 and CAR-T therapies. It improves T-cell signaling and effector function. CAR T cells were expanded in G-Rex 6M well plates during the manufacturing process for experimental assays.